Radical treatment not the only way, NICE stresses in prostate guideline
This article was originally published in Clinica
The UK Prostate Brachytherapy Advisory Group (PBAG) says that a new guideline on best practice for the diagnosis and treatment of prostate cancer represents a step forward for patient choice. The guideline, issued in late February by the National Institute for Health and Clinical Excellence (NICE), covers the tests, treatment, care and support that men who have suspected or diagnosed prostate cancer should be offered (not care for rare cancers). NICE clinical and public health director Professor
You may also be interested in...
The company is optimistic about a significant portion of eligible patients opting for its newly approved long-acting HIV therapy over daily, oral antiviral therapy.
After reviewing real-world data, the US agency says the decontamination systems should only be used for compatible facemasks and should not be used to clean a mask more than four times.
Under an extensive COVID-19 plan and executive order signed on 21 January, the US president explained how he’ll beef up testing and manufacturing of medtech to fight the virus.